(Q46880626)

26 December 2017

title

Determinants of discontinuation of initial highly active antiretroviral therapy regimens in a US HIV-infected patient cohort (English)

1 reference

26 December 2017

human immunodeficiency virus infectious disease

1 reference

United States of America

1 reference

based on heuristic

inferred from title

0 references

author name string

Yuan Y

1

1 reference

26 December 2017

L'italien G

2

1 reference

26 December 2017

Mukherjee J

3

1 reference

26 December 2017

Iloeje UH

4

1 reference

26 December 2017

publication date

1 April 2006

1 reference

26 December 2017

published in

HIV Medicine

1 reference

26 December 2017

volume

7

1 reference

26 December 2017

issue

3

1 reference

26 December 2017

page(s)

156-162

1 reference

26 December 2017

Changing patterns of mortality across Europe in patients infected with HIV-1. EuroSIDA Study Group.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00355.X

Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00355.X

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00355.X

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00355.X

Hyperlipidemia associated with protease inhibitor therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00355.X

Metabolic complications associated with antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00355.X

Once-a-day HAART: dream or reality?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00355.X

Reasons for modification and discontinuation of antiretrovirals: results from a single treatment centre.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00355.X

Insights into the reasons for discontinuation of the first highly active antiretroviral therapy (HAART) regimen in a cohort of antiretroviral naïve patients. I.CO.N.A. Study Group. Italian Cohort of Antiretroviral-Naïve Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00355.X

Comparison of the effectiveness of non-nucleoside reverse transcriptase inhibitor-containing and protease inhibitor-containing regimens using observational databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00355.X

Patterns of antiretroviral use in the United States of America: analysis of three observational databases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00355.X

Changing conditions and treatments in a dynamic cohort of ambulatory HIV patients: the HIV outpatient study (HOPS).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00355.X

Serial CD4 lymphocyte counts and development of AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00355.X

The relative prognostic value of plasma HIV RNA levels and CD4 lymphocyte counts in advanced HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00355.X

Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2006.00355.X

10.1111/J.1468-1293.2006.00355.X

21 January 2018

Identifiers

DOI

1 reference

26 December 2017

1 reference

26 December 2017